Surgery Partners (SGRY) Preferred Stock Liabilities (2017 - 2021)

Surgery Partners has disclosed Preferred Stock Liabilities across 5 years of filings, most recently posting $439.7 million for Q1 2021.

• Preferred Stock Liabilities for Q1 2021 came in at $439.7 million, up 8.7% year-over-year; the trailing twelve-month figure through Mar 2021 was $439.7 million (up 8.7% YoY), and the FY2020 annual result was $434.5 million, up 10.0% from the prior year.
• Preferred Stock Liabilities came in at $439.7 million for Q1 2021 at Surgery Partners, up from $434.5 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $439.7 million in Q1 2021 to a low of $330.8 million in Q4 2017.
• The 5-year median for Preferred Stock Liabilities is $376.6 million (2019), against an average of $379.4 million.
• Across the five-year window, Preferred Stock Liabilities advanced 8.62% in 2018 and climbed 10.0% in 2020, its largest moves.
• Surgery Partners' Preferred Stock Liabilities stood at $330.8 million in 2017, then rose by 8.62% to $359.3 million in 2018, then gained by 9.94% to $395.0 million in 2019, then gained by 10.0% to $434.5 million in 2020, then gained by 1.2% to $439.7 million in 2021.
• The last three Preferred Stock Liabilities figures came in at $439.7 million (Q1 2021), $434.5 million (Q4 2020), and $424.2 million (Q3 2020), per Business Quant data.